Radiant Biotherapeutics to present new data from lead oncology programme at SITC 2025 annual meeting

Join Pharma | Login

	Editorial


	A GOOD INITIATIVE BY DCGI
	Wednesday, November 5, 2025
	The Central Drugs Standard Control Organisation (CDCSO) has initiated discussions among the stakeholders to address the discrepancy in approval of new drugs, where the first applicant has to bear exorbitantly higher cost
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Radiant Biotherapeutics to present new data from lead oncology programme at SITC 2025 annual meeting
17:50 [IST]	SOUKYA acquires 6 acres in Hoskote; to foray into affordable Ayush healthcare, commits Rs. 1.25 crore investment for 100 bed unit
17:45 [IST]	Medanta launches advanced surgical heart failure clinic to transform comprehensive heart care
17:40 [IST]	Emcutix Biopharma unveils AquaOat with’s unique technological innovation
17:35 [IST]	Bayer expands indication of Kerendia in India to include heart failure with preserved and mildly reduced ejection fraction
17:30 [IST]	Venus Remedies expands exports portfolio In ASEAN with new marketing authorisations in Vietnam

more news >>

TOP NEWS


08:00 [IST]	Health ministry brings changes to sample size requirement in draft amendment of NDCT Rules
08:00 [IST]	AICDF launches major campaign against illegal drug marketers
08:00 [IST]	Pharmexcil plans global business delegations for FY 2025–26 to enhance Indian pharma exports
08:00 [IST]	KSMSC to procure Rs. 800 crore of medicines with strict quality control measures
08:00 [IST]	National Pharmaceutical Pricing Authority fixes retail price of 28 new drugs
08:00 [IST]	PCI asks institutions to submit SIF within extended deadline

more news >>

YESTERDAY'S NEWS


17:40 [IST]	Intas Pharma solidifies top 6 rank with double-digit growth in September 2025
16:15 [IST]	Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud
13:50 [IST]	Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation
13:40 [IST]	Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution
13:20 [IST]	Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%
13:10 [IST]	Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share

more news >>

INTERVIEW


Future of pharmacy trade lies in blending tradition with innovation
B Thirunavukkarasu, President, The Bangalore District Chemists and Druggists Association

Past Interviews...

	What's New?

Zydus Lifesciences net profit grows 38% in Q2FY26 Stagnant US sales put Sun Pharma’s net profit growth at only 2.5% to Rs. 3,137 crore in Q2 Active Pharmaceutical Ingredients (Chirakhan) Project Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200% Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers